Clinical Trials Directory

Trials / Terminated

TerminatedNCT00542347

Comparison of the Gastric Acid Suppressive Effects of Esomeprazole and Generic Omeprazole

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Queen's University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Proton pump inhibitors (PPI) are used to decrease stomach acid secretion. A generic form of omeprazole, one of the PPIs, is on the market. With cheaper than brand name PPIs, it is unclear whether generic omeprazole is as effective clinically. This study compares generic omeprazole with half-dose esomeprazole, the strongest brand name PPI. The half-dose esomeprazole is in fact cheaper than generic omeprazole. Healthy volunteers will take each medication in turn for 7 days and their stomach acid will be measured while taking each medication. We hypothesize that half-dose esomeprazole is better at suppressing stomach acid than generic omeprazole.

Conditions

Interventions

TypeNameDescription
DRUGEsomeprazole first* esomeprazole 20mg po once per day for 7 days * 24hr pH study on day 7 * followed by washout for 7 days * generic omeprazole 20mg po once per day for 7 days * 24hr pH study on day 7
DRUGGeneric omeprazole first* generic omeprazole 20mg po once per day for 7 days * 24hr pH study on day 7 * followed by washout for 7 days * esomeprazole 20mg po once per day for 7 days * 24hr pH study on day 7

Timeline

Start date
2007-09-01
Primary completion
2017-04-01
Completion
2018-07-01
First posted
2007-10-11
Last updated
2018-07-20

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00542347. Inclusion in this directory is not an endorsement.